CA21443-1 - 0x0000000000002BFB

Study Number: CA21443
Group Number: 1
Study Requirement: Healthy Male
Stipend: $3,150.00
Screening Stipend: $150.00

Study Criteria:

  • Age: 19 - 55
  • BMI: 19 - 32
  • Weight Restriction: minimum weight 111 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.
  • Route of Administration: Injection IV bolus/push; Oral
  • Blood Draws: 30

Study Schedule:

  • Schedule Type: Long Term
  • Study Length: One - 8 Night Stay & 1 Return (courtesy stays available between visits)

Screening Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Wednesday 1/24/2018
Friday 1/26/2018

Doctor Exam Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Wednesday 1/24/2018
Friday 1/26/2018

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Tuesday 2/6/2018 1:00:00 PM Wednesday 2/14/2018 10:15:00 AM 1 Lincoln
Return Wednesday 2/21/2018 9:00:00 AM Wednesday 2/21/2018 10:15:00 AM 1 Lincoln